To understand the involvement of UCHL1 in different cancers, future studies should look to selective and potent activity-based probes to facilitate identification of the substrates of UCHL1, and the mechanistic role played by these substrates in modulating ER expression in breast cancer, as well as in other disease contexts and in normal physiology. The gene discussed is ESR1; the disease is cancer.